It has been drawn to the publisher’s attention that this article [1] was inadvertently published with certain omissions. The authors apologize for the omissions in the published article.
The co-authors Nicolas Sluis-Cremer and Brian D. Herman, Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA have now been added as co-authors.
The following sentence has been added to the acknowledgements section: “The research in the N.S.–C laboratory was supported by a grant from the United States of America National Institutes of Health (GM068406)”
References
Penta , et al.: Design and synthesis of tetrahydrophthalimide derivatives as inhibitors of HIV-1 reverse transcriptase. Organic and Medicinal Chemistry Letters 2013, 3: 8. 10.1186/2191-2858-3-8
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found at 10.1186/2191-2858-3-8
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 2.0 International License ( https://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Penta, A., Ganguly, S. & Murugesan, S. Erratum to: Design and synthesis of tetrahydrophthalimide derivatives as inhibitors of HIV-1 reverse transcriptase. Org Med Chem Lett 3, 12 (2013). https://doi.org/10.1186/2191-2858-3-12
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/2191-2858-3-12